Amphastar Pharmaceuticals Inc

AMPHNASDAQ · USD
29.37USD0.00 (+1.74%)
10910

Amphastar Pharmaceuticals Inc (AMPH) Option Chain

Read more

Tracking the AMPH option chain helps you see every strike and expiry on Amphastar Pharmaceuticals Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AMPH options activity at a glance. Use our scanner to monitor the AMPH option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AMPH stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where AMPH options are being actively traded, and where they are not.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
Loading option chain…

As of Nov 13, 2026

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV Rank45.63% Moderate
  • Market cap (M$)1,253
  • 52 weeks high-5.26%
  • 52 weeks low76.50%
  • Analyst recommendationHold
    3.14
  • Target price$24.50
    -16.58% below the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-05
  • P/E13.27
  • Future P/E8.76
  • EPS (ttm)2.21
  • EPS growth next 5 years3.20%

As of Nov 13, 2026